Alpha and beta adrenergic blockade with orally administered labetalol in hypertension. Studies on blood volume, plasma renin and aldosterone and catecholamine excretion.

No abstract is available for this paper.

• Publication year

  1978

• Venue

  American Journal of Cardiology

• Publication date

  1978-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9149(78)90017-6PMID 343564
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adrenergic blockade in hypertension.

  1978cited by this paper
• Hemodynamic Effects of Labetalol, an Alpha and Beta Adrenergic Blocking Agent, in Hypertensive Subjects

  1977cited by this paper
• Beta-adrenergic blockade in hypertension.

  1977cited by this paper
• Interrelations between age and plasma renin, aldosterone and cortisol, urinary catecholamines, and the body sodium/volume state in normal man

  1977cited by this paper
• Interrelations among blood pressure, blood volume, plasma renin activity and urinary catecholamines in benign essential hypertension.

  1977cited by this paper
• Haemodynamic effects of long-term oral labetalol.

  1976cited by this paper
• A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.

  1976cited by this paper
• Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent.

  1976cited by this paper
• Combined alpha- and beta-adrenoreceptors blockade with oral labetalol in hypertensive patients with reference to haemodynamic effects at rest and during exercise.

  1976cited by this paper
• Experience with labetalol in hypertension.

  1976cited by this paper
• Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent.

  1976cited by this paper
• Controlled comparison of labetalol and propranolol in the management of severe hypertension.

  1976cited by this paper
• Labetalol in resistant hypertension.

  1976cited by this paper
• Comparative anti-hypertensive effects of labetalol and the combination of oxprenolol and phentolamine.

  1976cited by this paper
• [Interrelations between blood pressure, blood volume, plasma renin and urinary catecholamines during beta-blockade in essential hypertension (author's transl)].

  1976cited by this paper
• Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension.

  1976cited by this paper
• Double-blind trial of labetalol.

  1976cited by this paper
• Labetalol in long-term treatment of hypertension.

  1976cited by this paper
• Labetalol in long-term treatment of hypertension.

  1976cited by this paper
• Beta-adrenergic blockade in diuretic-treated patients with essential hypertension.

  1975cited by this paper
• Long term treatment of moderate hypertension with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exercise

  1975cited by this paper
• β-Adrenergic Blockade in Diuretic-Treated Patients with Essential Hypertension

  1975cited by this paper
• The effects of oral AH 5158, a combined α and β-adrenoceptor antagonist, in healthy volunteers.

  1974cited by this paper
• Local α-adrenoceptor mediated feed-back inhibition of catecholamine release from the adrenal medulla?

  1974cited by this paper
• Inhibition of adrenergic function in the treatment of hypertension.

  1974cited by this paper
• Vasodilator drugs in the treatment of hypertension.

  1974cited by this paper
• Dynamic studies of aldosterone in anephric man.

  1973cited by this paper
• Evaluation of practolol in hypertension. Effects on sympathetic nervous system and renin responsiveness.

  1973cited by this paper
• Radioimmunoassay for aldosterone without chromatography. 2. Determination of plasma aldosterone.

  1973cited by this paper
• Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.

  1972cited by this paper
• Alpha and beta adrenergic blockade in hypertension.

  1972cited by this paper
• Studies of the control of plasma aldosterone concentration in normal man. I. Response to posture, acute and chronic volume depletion, and sodium loading.

  1972cited by this paper
• Inhibition of catecholamine uptake in the isolated rat heart by haloalkylamines related to phenoxybenzamine

  1972cited by this paper
• Studies of the control of plasma aldosterone concentration in normal man. II. Effect of dietary potassium and acute potassium infusion.

  1972cited by this paper
• The renin system: Variations in man measured by radioimmunoassay or bioassay.

  1972cited by this paper
• Relationship of extracellular fluid volume to the development of drug resistance in the hypertensive patient.

  1971cited by this paper
• Plasma volume changes with long-term beta-adrenergic blockade.

  1971cited by this paper
• Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytoma.

  1966cited by this paper
• Propranolol in hypertension.

  1966cited by this paper
• BODY CONSTITUENTS AND FUNCTIONS IN RELATION TO HEIGHT AND WEIGHT.

  1964cited by this paper
• EFFECT OF COCAINE, PHENOXYBENZAMINE AND PHENTOLAMINE ON THE CATECHOLAMINE OUTPUT FROM SPLEEN AND ADRENAL MEDULLA.

  1963cited by this paper
• A method for the fluorimetric determination of adrenaline and noradrenaline in tissues.

  1958cited by this paper

• Screening for primary aldosteronism in pregnancy.

  2021cites this paper
• Chapter 48 – Extrarenal Potassium Metabolism

  2013cites this paper
• Combined α- and β-Receptor Inhibition in the Treatment of Hypertension

  2012cites this paper
• Pharmacology of Combined α-β-Blockade I

  2012cites this paper
• Extrarenal Potassium Metabolism

  2008cites this paper
• Chapter 31 – Pharmacologic Treatment of Hypertension

  2007cites this paper
• Antihypertensive and metabolic effects of nifedipine and labetalol alone and in combination in primary hypertension

  2004cites this paper
• Cardiovascular regulation during administration of co-dergocrine to normal subjects

  2004cites this paper
• Clinical experience with dual-acting drugs in hypertension

  2004cites this paper
• Labetalol and other agents that block both alpha- and beta-adrenergic receptors.

  1994cites this paper
• Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats.

  1994cites this paper
• [Metabolic and cardiovascular profile in antihypertensive treatment with urapidil].

  1990cites this paper
• Drugs Acting on Multiple Receptors: β-Blockers with Additional Properties

  1990cites this paper
• Regulation of Aldosterone Biosynthesis

  1988cites this paper
• Labetalol in the Treatment of Essential Hypertension: A Single‐Blind Dose Ranging Study

  1986cites this paper
• Cardiovascular and metabolic profile during intervention with urapidil in humans.

  1985cites this paper
• Current status of labetalol, the first alpha- and beta-blocking agent.

  1985cites this paper
• Combined alpha- and beta-receptor inhibition in the treatment of hypertension.

  1984cites this paper
• The Pharmacodynamics of Alpha and Beta Blockade

  1984cites this paper
• Effect of indoramin, labetalol and alinidine on sympathetic function in normal man.

  1984cites this paper
• Pharmacology of combined alpha-beta-blockade. I.

  1984cites this paper
• The Response of Plasma Catecholamines to Receptor Antagonists

  1984cites this paper
• Effects of antihypertensive treatment on peripheral flow of the lower limbs.

  1984cites this paper
• Labetalol.

  1983cites this paper
• Alpha-adrenergic blockade in the treatment of essential hypertension.

  1983cites this paper
• Labetalol: A Review of Its Pharmacology, Pharmacokinetics, Clinical Uses and Adverse Effects

  1983cites this paper
• Alpha‐adrenoceptor blockade by labetalol during long‐term dosing

  1983cites this paper
• Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.

  1983cites this paper
• Sympathetic nervous activity and the pressor effect of noradrenaline under chronicα-β-adrenoceptor blockade with labetalol in hypertension

  1983cites this paper
• Labetalol (Trandate, Glaxo Inc.; Normodyne, Schering Corp.)

  1983cites this paper
• Hemodynamic effects of intravenous labetalol in essential hypertension

  1983cites this paper
• The use of labetalol in Japan: results of multicentre clinical trials.

  1982cites this paper
• Reversal of diuretic-induced increases in serum low-density-lipoprotein cholesterol by the betablocker pindolol.

  1982cites this paper
• Intravenous labetalol in severe hypertension.

  1982cites this paper
• The treatment of hypertension by labetalol‐a new alpha‐ and beta‐adrenoreceptor blocking agent

  1982cites this paper
• Prizidilol in Essential Hypertension: Long‐Term Effects on Plasma Volume, Extracellular Fluid Volume, and Central Hemodynamics at Rest and During Exercise

  1982cites this paper
• The hypotensive effect of a single daily dose of labetalol: a preliminary study.

  1982cites this paper
• Acebutolol: A Review of its Pharmacology, Pharmacokinetics, Clinical Uses, and Adverse Effects

  1982cites this paper
• Blood pressure, body fluid volumes and glomerular filtration rate during treatment with labetalol in essential hypertension.

  1981cites this paper
• [New blood pressure-reducing medication].

  1981cites this paper
• Effects of long-term high-dose labetalol on blood pressure in patients with severe hypertension resistant to previous therapy.

  1980cites this paper
• The pharmacologic alteration of renin release.

  1980cites this paper
• Acute Effects of Labetalol on Haemodynamics and Response to Emotional Stress in Hypertensive Patients

  1980cites this paper
• Effects of chronic alpha and beta adrenoceptor blockade with labetalol on plasma catecholamines and renal function in hypertension

  1980cites this paper
• Labetalol in Essential Hypertension

  1980cites this paper
• Labetalol and propranolol in mild hypertensives: comparison of blood pressure and plasma volume effects.

  1980cites this paper
• [Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].

  1980cites this paper
• Experience with labetalol in essential hypertension.

  1980cites this paper
• Blood pressure, plasma volume, extracellular volume and glomerular filtration rate during treatment with labetalol in essential hypertension.

  1980cites this paper
• Labetalol and urinary catecholamines.

  1979cites this paper
• Akute kombinierte Alpha- und Betarezeptorenblockade bei essentieller Hypertonie: Wirkungen auf Blutdruck, Nierenfunktion, Renin und Aldosteron

  1979cites this paper
• [Acute combined alpha- and beta-adrenergic blockade in essential hypertension: effects on blood pressure, renal function, renin, and aldosterone].

  1979cites this paper
• A comparative study of methyldopa and labetalol in the treatment of hypertension.

  1979cites this paper
• [Prazosin in the combined treatment of moderate to severe hypertension].

  1979cites this paper
• Increased catecholamine excretion after labetalol therapy: a spurious effect of drug metabolites.

  1979cites this paper
• Effect of oral labetalol on plasma catecholamines, renin and aldosterone in patients with severe arterial hypertension

  1979cites this paper
• A comparative study of methyldopa and labetalol in the treatment of hypertension.

  1979cites this paper
• Cardiovascular and endocrine profile of adrenergic neurone blockade in normal and hypertensive man.

  1979cites this paper
• Labetalol: A Review of its Pharmacology and Therapeutic Use in Hypertension

  1978cites this paper